Blin J, Dubois B, Bonnet A M, Vidailhet M, Brandabur M, Agid Y
Service de Neurologie et Neuropsychologie, Hôpital de la Salpêtrière, Paris, France.
J Neurol Neurosurg Psychiatry. 1991 Sep;54(9):780-2. doi: 10.1136/jnnp.54.9.780.
The influence of age of onset of Parkinson's disease on the severity and the pattern of motor symptoms was investigated by comparing the motor scores with and without levodopa therapy in two groups of patients divided according to age of onset (early less than 50, late greater than 60 years) and matched for disease duration (n = 69 in each group, Study I). The baseline score, that is, the motor disability of patients when off levodopa, was similar in the early- and late- onset groups. In contrast, the residual motor score, assessed when the effect of levodopa treatment was maximum and stable, was significantly higher in the late onset group. When the two groups of patients were matched, in addition, for their residual motor score, (n = 54 in each group, Study II), no difference was observed between the early and late onset groups, except for gait disorder which was more severe in older patients. These results suggest that age of onset mainly affects the response to levodopa therapy, because it may increase the prevalence of non-dopaminergic lesions of the brain, including those responsible for gait disorders.
通过比较两组根据发病年龄(早发型小于50岁,晚发型大于60岁)划分且病程匹配的患者(每组n = 69,研究I)在接受左旋多巴治疗和未接受左旋多巴治疗时的运动评分,研究帕金森病发病年龄对运动症状严重程度和模式的影响。早发型组和晚发型组的基线评分,即患者未服用左旋多巴时的运动功能障碍程度相似。相比之下,在左旋多巴治疗效果达到最大且稳定时评估的残余运动评分,晚发型组显著更高。此外,当两组患者根据残余运动评分进行匹配时(每组n = 54,研究II),早发型组和晚发型组之间未观察到差异,但老年患者的步态障碍更为严重。这些结果表明,发病年龄主要影响对左旋多巴治疗的反应,因为它可能增加脑非多巴胺能损伤的发生率,包括导致步态障碍的损伤。